CLDN4 and mesothelioma: They discovered that all benign effusion patients with RMCs tested negative for Claudin-4, while only one mesothelioma case (1.6%) and 131/137 (95.6%) adenocarcinoma cases (including all 34 cases of lung adenocarcinoma) tested positive (20).